An investor consortium to acquire HistoSonics for $2.25bn.

An investor consortium, including K5 Global, Bezos Expeditions, Wellington Management, Alpha JWC Ventures, Alpha Wave Ventures, Venture Investors Health Fund, Lumira Ventures, Hatteras Venture Partners, Early Stage Partners, Amzak Health, HealthQuest Capital, Yonjin Venture, the State of Wisconsin Investment Board, the State of Michigan Retirement System and JJDC, agreed to acquire HistoSonics, a medical device company, for $2.25bn. “What stood out with HistoSonics wasn’t just the technology, it was the speed and clarity with which the team turned a breakthrough into real clinical traction. Hospitals are continuing to order systems, patient demand is surging, and the clinical results speak for themselves. We partnered with HistoSonics because this is one of those rare moments where the science, the execution, and the opportunity all align, and we are here to ensure it reaches every hospital in the world,” Bryan Baum, K5 Global Co-Founder and Managing Partner.